News Releases Keyword search Year None2023202220212020201920182017201620152014201320122011201020092008 5/10/2023 AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update 4/27/2023 AcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023 4/5/2023 AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals 3/30/2023 AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update 3/21/2023 AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023 3/14/2023 AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals 3/1/2023 AcelRx Pharmaceuticals Announces Peer-Reviewed Publication On the Use of DSUVIA® For In-Office Rhinology Procedures Print Page RSS Feeds
Keyword search Year None2023202220212020201920182017201620152014201320122011201020092008 5/10/2023 AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update 4/27/2023 AcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023 4/5/2023 AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals 3/30/2023 AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update 3/21/2023 AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023 3/14/2023 AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals 3/1/2023 AcelRx Pharmaceuticals Announces Peer-Reviewed Publication On the Use of DSUVIA® For In-Office Rhinology Procedures
5/10/2023 AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
3/30/2023 AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
3/21/2023 AcelRx to Host Full Year and Fourth Quarter 2022 Financial Results Call and Webcast on March 30, 2023
3/1/2023 AcelRx Pharmaceuticals Announces Peer-Reviewed Publication On the Use of DSUVIA® For In-Office Rhinology Procedures
